Genetic variation at glucose and insulin trait loci and response to glucose-insulin-potassium (GIK) therapy: the IMMEDIATE trial

被引：6

作者：

Ellis, K. L. ^{[1
]}

Zhou, Y. ^{[2
]}

Beshansky, J. R. ^{[3
]}

Ainehsazan, E. ^{[1
]}

Yang, Y. ^{[1
]}

Selker, H. P. ^{[3
]}

Huggins, G. S. ^{[4
]}

Cupples, L. A. ^{[2
]}

Peter, I. ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA

[2] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA

[3] Tufts Univ, Sch Med, Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA

[4] Tufts Med Ctr, Ctr Translat Genom, Mol Cardiol Res Inst, Boston, MA USA

来源：

PHARMACOGENOMICS JOURNAL | 2015年 / 15卷 / 01期

基金：

美国国家卫生研究院;

关键词：

GENOME-WIDE ASSOCIATION; ACUTE CORONARY SYNDROMES; RANDOMIZED CONTROLLED-TRIAL; TYPE-2 DIABETES RISK; INTRAVENOUS GLUCOSE; SUSCEPTIBILITY LOCI; VARIANTS; METAANALYSIS; SEQUENCE; RELEASE;

D O I：

10.1038/tpj.2014.41

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

The mechanistic effects of intravenous glucose, insulin and potassium (GIK) in cardiac ischemia are not well understood. We conducted a genetic sub-study of the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency care (IMMEDIATE) Trial to explore effects of common and rare glucose and insulin-related genetic loci on initial to 6-h and 6- to 12-h change in plasma glucose and potassium. We identified 27 NOTCH2/ADAM30 and 8 C2CD4B variants conferring a 40-57% increase in glucose during the first 6 h of infusion (P < 5.96 x 10(-6)). Significant associations were also found for ABCB11 and SLC30A8 single-nucleotide polymorphisms (SNPs) and glucose responses, and an SEC61A2 SNP with a potassium response to GIK. These studies identify genetic factors that may impact the metabolic response to GIK, which could influence treatment benefits in the setting of acute coronary syndromes (ACS).

引用

页码：55 / 62

页数：8

共 50 条

[41] Experience using high-dose glucose-insulin-potassium (GIK) in critically ill patients
Slob, Elise M. A.
Shulman, Rob
Singer, Mervyn
JOURNAL OF CRITICAL CARE, 2017, 41 : 72 - 77
[42] The effects of glucose-insulin-potassium (GIK) infusion on the outcomes of coronary artery bypass graft (CABG)
Saliby, A
Brass, B
Seto-Young, D
Tranbaugh, R
Poretsky, L
DIABETES, 2005, 54 : A519 - A519
[43] GLUCOSE INSULIN POTASSIUM (GIK) IN TREATMENT OF CONGESTIVE CARDIOMYOPATHY
GWATA, T
EDWARDS, IR
CENTRAL AFRICAN JOURNAL OF MEDICINE, 1980, 26 (12) : 249 - 250
[44] HEMODYNAMIC EVALUATION OF GLUCOSE-INSULIN-POTASSIUM INFUSIONS
ESPINA, L
GOULD, L
REDDY, CVR
GOMPRECH.RF
CIRCULATION, 1973, 48 (04) : 161 - 161
[45] Positive effects of glucose-insulin-potassium (GIK) infusion in patients with STEMI and thrombolytic therapy: 1 month follow up
Krljanac, G
Vasiljevic, Z
Radovanovic, M
Mitrovic, P
Milic, N
HEART, 2004, 90 : A4 - A5
[46] GLUCOSE-INSULIN-POTASSIUM (GIK) THERAPY FOR TREATMENT OF ACUTE MYOCARDIAL-INFARCTION - HAS IT BEEN ABANDONED TOO EARLY
FATHORDOUBADI, F
BEATT, KJ
CIRCULATION, 1995, 92 (08) : 112 - 112
[47] THE GLUCOSE-INSULIN-POTASSIUM CONTROVERSY - A POSSIBLE EXPLANATION
DENNIS, SC
FRASCH, HF
HALMI, B
ANDERSON, GJ
CLINICAL RESEARCH, 1983, 31 (02): : A178 - A178
[48] EFFECT OF PREOPERATIVE GLUCOSE-INSULIN-POTASSIUM (GIK) ON MYOCARDIAL GLYCOGEN, HEMODYNAMICS AND ELECTROPHYSIOLOGY IN DIRECT MYOCARDIAL REVASCULARIZATION
IYENGAR, SRK
CHARRETTE, EJP
IYENGAR, CKS
WASAN, S
LYNN, RB
CIRCULATION, 1975, 52 (04) : 198 - 198
[49] Glucose-insulin-potassium in acute myocardial infarction
Swaminathan, R
LANCET, 1999, 353 (9168): : 1968 - 1968
[50] Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial
Apstein, CS
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (21): : 2596 - 2597

← 1 2 3 4 5 →